Singulex Revenue and Competitors

Location

$227.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Singulex's estimated annual revenue is currently $4.6M per year.(i)
  • Singulex's estimated revenue per employee is $77,500
  • Singulex's total funding is $227.3M.

Employee Data

  • Singulex has 59 Employees.(i)
  • Singulex grew their employee count by 0% last year.

Singulex's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2591.1M80577%N/AN/A
Add Company

What Is Singulex?

Our focus to date has been the commercialization of our proprietary ultrasensitive instrumentation and assay systems for nucleic acid and protein detection, measurement, and analysis. Singulex is a molecular tools and diagnostics company. We intend to sell equipment, reagents, related software and supplies, and contract research services, as well as technology licenses for integration with other systems and applications.

keywords:Biotechnology

$227.3M

Total Funding

59

Number of Employees

$4.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Singulex News

2022-04-17 - Todos Medical Appoints Philippe Goix as Chief Commercial ...

Goix served as President & CEO of Singulex, Inc., a personalized healthcare diagnostics company focused on improving outcomes in the $300...

2022-04-17 - Movers & Shakers: John Maraganore, Larry Alstiel, Brad ...

Between 2004 through 2013, Goix served as president and CEO of Singulex, Inc. In academia, Goix served as a research scientist at Stanford...

2013-09-26 - Singulex Closes $55M Financing

Singulex, Inc., a Alameda, CA-based provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, closed a $55m financing. It includes a debt facility for up to $40m from Oxford Finance and Silicon Valley Bank and $15m equity financing (closed in ...

2009-01-14 - Singulex lands $19M for diagnostic systems

Singulex, an Alameda, Calif.-based biotech firm, just raised $19 million in fifth-round funding to commercialize technology that uses protein biomarkers to diagnose cardiovascular and other disorders. Already in clinical trials, its system gauges changes in biomarker levels in the bloodstream to ...

2007-06-07 - Biomarker-diagnostics developer Singulex validates $19M

Hayward, Calif.-based Singulex, a developer of sensitive molecular-detection systems, raised $19 million in a fourth funding round. The company’s release is here. The company is developing an analysis system, called Erenna, plus related “assays,” or specially designed biochemical tests, that ar ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.5M61-9%N/A
#2
$9.2M6410%N/A
#3
$20.2M695%N/A
#4
$11.2M69-3%N/A
#5
$9.1M70N/AN/A